Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...